Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Other Working Capital Changes (2020 - 2025)

Maravai Lifesciences Holdings (MRVI) has 6 years of Other Working Capital Changes data on record, last reported at -$1.2 million in Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 2.7% year-over-year to -$1.2 million; the TTM value through Dec 2025 reached -$1.6 million, up 74.19%, while the annual FY2025 figure was -$1.6 million, 74.19% up from the prior year.
  • Other Working Capital Changes reached -$1.2 million in Q4 2025 per MRVI's latest filing, down from $290000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $23.0 million in Q1 2023 and bottomed at -$21.3 million in Q2 2023.
  • Average Other Working Capital Changes over 5 years is -$640500.0, with a median of -$1.2 million recorded in 2024.
  • Peak YoY movement for Other Working Capital Changes: tumbled 1322.39% in 2023, then skyrocketed 12217.19% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at $13.1 million in 2021, then crashed by 120.91% to -$2.7 million in 2022, then tumbled by 145.59% to -$6.7 million in 2023, then surged by 82.88% to -$1.2 million in 2024, then dropped by 2.7% to -$1.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were -$1.2 million in Q4 2025, $290000.0 in Q3 2025, and $7.8 million in Q2 2025.